Mass spectrometry-based de novo sequencing of the anti-FLAG-M2 antibody using multiple proteases and a dual fragmentation scheme
preprint · bioRxiv · 2021
| Date | 2021-01-08 |
| Type | preprint |
| Venue | bioRxiv |
| Publisher | openRxiv |
| Contribution | downstream-application |
| DOI | 10.1101/2021.01.07.425675 |
| Citations (OpenAlex) | 3 |
Peer-reviewed version: Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation Scheme (2021-07-02, Journal of Proteome Research)
Abstract
Antibody sequence information is crucial to understanding the structural basis for antigen binding and enables the use of antibodies as therapeutics and research tools. Here we demonstrate a method for direct de novo sequencing of monoclonal IgG from the purified antibody products. The method uses a panel of multiple complementary proteases to generate suitable peptides for de novo sequencing by LC-MS/MS in a bottom-up fashion. Furthermore, we apply a dual fragmentation scheme, using both stepped high-energy collision dissociation (stepped HCD) and electron transfer high-energy collision dissociation (EThcD) on all peptide precursors. The method achieves full sequence coverage of the monoclonal antibody Herceptin, with an accuracy of 99% in the variable regions. We applied the method to sequence the widely used anti-FLAG-M2 mouse monoclonal antibody, which we successfully validated by remodeling a high-resolution crystal structure of the Fab and demonstrating binding to a FLAG-tagged target protein in Western blot analysis. The method thus offers robust and reliable sequences of monoclonal antibodies.
Methods and tools
- Multi-protease dual-fragmentation antibody sequencing: Direct de novo sequencing of monoclonal IgG from the purified product with a panel of complementary proteases and both stepped HCD and EThcD on every precursor, demonstrated on the anti-FLAG-M2 antibody.
Data used
- Anti-FLAG-M2 antibody sequencing (as deposited) · PXD023419
Cites (8)
- Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination (2017) both
- Automated Antibody De Novo Sequencing and Its Utility in Biopharmaceutical Discovery (2017) both
- De Novo MS/MS Sequencing of Native Human Antibodies (2017) both
- Complete De Novo Assembly of Monoclonal Antibody Sequences (2016) both
- Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies (2016) both
- Primary sequence determination of a monoclonal antibody against α-synuclein using a novel mass spectrometry-based approach (2012) both
- Resurrection of a clinical antibody: Template proteogenomic de novo proteomic sequencing and reverse engineering of an anti‐lymphotoxin‐α antibody (2011) both
- Automated de novo protein sequencing of monoclonal antibodies (2008) both